Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases

Table 1 The main clinicopathological features and outcomes of 20 MEITL cases.

case	Sex	Age	Location	Grossly	Cell morphology	Infiltration depth	lymph node involvements	CD3	CD5	CD4	CD8	CD56	Postoperative treatment	Outcomes(months)
1	M	51	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	NA	D(6.5)
2	M	56	small intestine	mass	M+P	Full-thickness	Y	+	-	-	+	+	CHOP	D(24)
3	M	69	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	CHOPE	D(9)
4	F	59	small intestine	mass	M	Full-thickness	N	+	-	-	+	+	CHOP+ASCT	D(9)
5	F	81	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	NA	D(0.5)
6	M	58	small intestine	ulcer	M	Mucosa and submucosa	N	+	-	-	-	+	CHOP	D(7.5)
7	M	28	small intestine	mass	M	Full-thickness	N	+	-	-	+	-	CHOPE	D(7)
8	M	35	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	NA	D(0.5)
9	M	63	small intestine	mass	M	Full-thickness	N	+	-	-	+	+	DA-CHOPE	D(9)
10	M	66	small intestine	perforation	M	Full-thickness	Y	+	-	+	+	-	NA	D(0.5)
11	M	52	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	CHOPE	D(56)
12	F	59	small and large intestine	mass	M	Full-thickness	N	+	-	-	-	-	DA-CHOPE	D(58)
13	M	54	small intestine	perforation	M	Full-thickness	Y	+	-	-	+	+	CHOP	D(6)
14	M	70	small intestine	perforation	M	Full-thickness	N	+	-	-	+	-	DA-CHOPE	A(101)
15	F	46	large intestine	mass	M	Mucosa and submucosa	N	+	-	+	+	+	CHOPE+ASCT	D(10)
16	M	60	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	DA-CHOPE+ASCT	D(6)
17	M	81	large intestine	mass	M	Full-thickness	N	+	-	-	+	-	Mini-CHOP2	D(26)
18	M	71	small intestine	perforation	M	Full-thickness	N	+	-	-	+	+	CHOPE	NA
19	F	51	small intestine	ulcer	M	Full-thickness	N	+	-	-	+	+	CHOPE	D(12.5)
20	F	39	small intestine	perforation	M	Full-thickness	N	+	-	-	-	+	NA	D(1.5)
No (%)								20 (100)	0 (100)	2 (10)	17 (85)	15 (75)

Sex: M-male, F-female; Cell morphology: M-monomorphic, P-pleomorphic; lymph node involvements: Y- with lymph node involvements, N-without lymph node involvements; Postoperative treatment: NA- with no treatment, C-cyclophosphamide, H- adriamycin, O- vincristine, P-prednisone, E-etoposide, ASCT- autologous hematopoietic stem cell transplantation; Outcomes(months): D- dead, A- alive, NA- lost to follow-up

ISSN: 1746-1596